Shortages of many generic drugs have plagued the U.S. health system for decades. The leading cause of drug shortages is quality issues at manufacturing plants, which are mostly overseas. Some experts argue that bringing pharmaceutical production back to the U.S. will help companies and regulators better monitor manufacturing and avoid a variety of issues.
Matt Blois talks to Michael Alkire, CEO at Premier, about how moving drug manufacturing overseas disrupted the quality of some drugs being...
https://www.freightwaves.com/news/repatriating-the-us-drug-supply-medically-necessary